Lifecore Biomedical, Inc. LFCR HA manufacturing — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Lifecore Biomedical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lifecore Biomedical, Inc.'s ha manufacturing — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lifecore Biomedical, Inc.'s HA manufacturing — revenue?
- Lifecore Biomedical, Inc. (LFCR) reported HA manufacturing — revenue of $7.42M in Q1 2026.
- How has Lifecore Biomedical, Inc.'s HA manufacturing — revenue changed year-over-year?
- Lifecore Biomedical, Inc.'s HA manufacturing — revenue decreased by 42.6% year-over-year, from $12.93M to $7.42M.
- What does HA manufacturing — revenue mean?
- This metric represents the total gross revenue generated from the production and sale of injectable-grade Hyaluronic Acid. It reflects the commercial performance and market demand for the company's specialized fermentation-based product offerings. Tracking this revenue stream helps investors evaluate the growth trajectory and competitive positioning of the company's proprietary material manufacturing business.